Aldeyra Therapeutics (ALDX) Tax Provisions (2019 - 2020)
Aldeyra Therapeutics (ALDX) posted Tax Provisions of -$479265.0 for Q4 2020, down 4905.63% on a QoQ basis from $9973.0 in Q4 2019, and down 4905.63% year-over-year from $9973.0 in Q1 2020.
Aldeyra Therapeutics (ALDX) Tax Provisions (2019 - 2020) Analysis & Trends
Aldeyra Therapeutics' Tax Provisions history runs 2 years deep, the most recent figure standing at -$479265.0 for Q4 2020.
- Quarterly Tax Provisions fell 4905.63% year-over-year to -$479265.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$479265.0 (up 63.13% YoY) and the FY2020 annual result came in at -$479265.0, up 63.13% from the prior year.
- Tax Provisions was -$479265.0 for Q4 2020 at Aldeyra Therapeutics, down from $9973.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $9973.0 in Q4 2019 and bottomed at -$1.3 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -479,265.00 |
| Dec 31, 2019 | 9,973.00 |
| Jun 30, 2019 | -9,973.00 |
| Mar 31, 2019 | -1.30 Mn |